Genetic variation in p53 and ATM haplotypes and risk of glioma and meningioma
Beatrice Malmer(Mayo Clinic), Roger Henriksson(Umeå University), Henrik Grönberg(Karolinska Institutet), Maria Feychting(Karolinska Institutet), Anthony J. Swerdlow(Institute of Cancer Research), Anssi Auvinen(Tampere University of Applied Sciences), Nadejda Mudie(Institute of Cancer Research), Stefan Lönn(Hallands sjukhus Halmstad), Anders Ahlbom(Karolinska Institutet), Tiina Salminen, Christoffer Johansen(University of Copenhagen), Helle Collatz Christensen(Region Zealand), Sara Lindström(University of Washington), Anne Kiuru(Radiation and Nuclear Safety Authority), Minouk J. Schoemaker(Institute of Cancer Research)
Cited by 61
Related Papers
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
|New England Journal of Medicine|2014|3.5k
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
|Nature Genetics|2018|1k
Genome-wide association study identifies five susceptibility loci for glioma
|Nature Genetics|2009|797